USPTO serial 99866605
STRATAMAP
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- BROWNE, LUCY E
- Law office
- TMO LAW OFFICE 125
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with STRATAMAP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Diego, CA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Katherine McMorrow
Katherine McMorrow Baker & Hostetler LLP1900 Avenue of the Stars, Suite 2700Los Angeles, CA 90067United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use; Chemical reagents for sequencing dna, rna, proteins, and nucleic acids, for research and scientific purposes; Diagnostic reagents and preparations, other than for medical use; Agents, reagents, assays, enzymes, nucleotides, buffers, chemical preparations, and biological preparations for scientific and research use, including in the fields of genotyping, medical research, dental research, clinical research, metagenomics, biotechnology, disease treatment research, dietary supplement research, fungicide research, herbicide research, drug development, pharmaceutical research, multi-omics, spatial transcriptomics, medical laboratory research, life sciences, biology, microbiology, agriculture, forensics, food safety, cosmetics, dermatology, genetic testing, nucleic acid sequencing, protein sequencing, genetics, prenatal screening and testing, diseases, in vitro diagnostic research, infectious diseases, reproductive health, neonatal intensive care, and personalized medicine, not for medical purposes; Reagent kits comprising reagents and a printed instructional protocol for use thereof, for non-medical purposes; Kits containing nucleotides, reagents, enzymes, enzyme substrates, agents, assays, buffers, chemical preparations, or biological preparations for use thereof for non-medical purposes; Kits comprising nucleotides, reagents, enzymes, enzyme substrates, agents, assays, buffers, chemical preparations, biological preparations, or flow cells for scientific and research use, including in the fields of genotyping, medical research, dental research, clinical research, metagenomics, biotechnology, disease treatment research, dietary supplement research, fungicide research, herbicide research, drug development, pharmaceutical research, multi-omics, spatial transcriptomics, medical laboratory research, life sciences, biology, microbiology, agriculture, forensics, food safety, cosmetics, dermatology, genetic testing, nucleic acid sequencing, protein sequencing, genetics, prenatal screening and testing, diseases, in vitro diagnostic research, infectious diseases, reproductive health, neonatal intensive care, and personalized medicine, not for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 23, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 23, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 9, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 4, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 4, 2026 | NWAP | NEW APPLICATION ENTERED | — |